BURAN: Effects of Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma using Functional Respiratory Imaging Parameters
Latest Information Update: 27 Mar 2025
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma; Eosinophilia
- Focus Therapeutic Use
- Acronyms BURAN
- Sponsors AstraZeneca; AstraZeneca AB
Most Recent Events
- 14 Aug 2024 Status changed from active, no longer recruiting to completed.
- 18 Jul 2024 This trial has been completed in Portugal, according to European Clinical Trials Database record.
- 19 Apr 2024 Status changed from recruiting to active, no longer recruiting.